arrow
A

Anne Patsouris

institut de cancerologie de louest
H指数:21
被引数:2,435

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Nivolumab in combination with ipilimumab versus capecitabine as post-operative treatment for triple negative breast cancer patients with residual disease after neoadjuvant chemotherapy: a multicentre, randomized, open-label phase II trial – BREASTIMMUNE-03

纳武利尤单抗联合伊匹木单抗与卡培他滨作为新辅助化疗后仍有残留病灶的三阴性乳腺癌患者的术后治疗:一项多中心、随机、开放标签的II期试验——BREASTIMMUNE-03

2025-11-210
OAAI
A Rac-specific competitive inhibitor of guanine nucleotide binding reduces metastasis in triple-negative breast cancer

一种Rac特异性竞争性鸟嘌呤核苷酸结合抑制剂可降低三阴性乳腺癌的转移

2025-07-080
OAAI
Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer
2024-06-256
PRE
p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane
2024-01-050
PRE
First-line real-world treatment patterns and survival outcomes in women younger or older than 40 years with metastatic breast cancer in the real-life multicenter French ESME cohort
2024-01-014
PRE
Atezolizumab and paclitaxel as first line therapy in advanced triple-negative breast cancer patients included in the French early access program
2023-08-184
OAAI
Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations
2022-10-075
OA
Efficacy of trastuzumab emtansine (T-DM1) and lapatinib after dual HER2 inhibition with trastuzumab and pertuzumab in patient with metastatic breast cancer: Retrospective data from a French multicenter real-life cohort
BREAST
IF7.9
2022-06-014
OAAI
Original Research Impact of lobular versus ductal histology on overall survival in metastatic breast cancer: a French retrospective multicentre cohort study
2022-03-0117
PRE
Clinicopathological characteristics and prognosis of breast cancer patients with isolated central nervous system metastases in the multicentre ESME database
2022-02-262
OAAI
Real-world evidence of the management and prognosis of young women (≤40 years) with de novo metastatic breast cancer
2022-01-213
OAAI